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Oct4, along with Sox2 and Klf4 (SK), can induce pluripotency but structurally similar factors
like Oct6 cannot. To decode why Oct4 has this unique ability, we compare Oct4-binding,
accessibility patterns and transcriptional waves with Oct6 and an Oct4 mutant defective in
the dimerization with Sox2 (Oct4defSox2). We ﬁnd that initial silencing of the somatic pro-
gram proceeds indistinguishably with or without Oct4. Oct6 mitigates the mesenchymal-to-
epithelial transition and derails reprogramming. These effects are a consequence of differ-
ences in genome-wide binding, as the early binding proﬁle of Oct4defSox2 resembles Oct4,
whilst Oct6 does not bind pluripotency enhancers. Nevertheless, in the Oct6-SK condition
many otherwise Oct4-bound locations become accessible but chromatin opening is com-
promised when Oct4defSox2 occupies these sites. We ﬁnd that Sox2 predominantly facilitates
chromatin opening, whilst Oct4 serves an accessory role. Formation of Oct4/Sox2 hetero-
dimers is essential for pluripotency establishment; however, reliance on Oct4/Sox2 hetero-
dimers declines during pluripotency maintenance.
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D eﬁned cocktails of transcription factors (TFs) are capableof interconverting cell types from different lineages and toreprogram somatic donor cells to self-renewing plur-
ipotent cells1–3. The induction of pluripotent stem cells (iPSCs)
from ﬁbroblasts by Oct4, Sox2, Klf4, and c-Myc (OSKM) is a
widely used model system to study the underlying molecular
mechanisms of cell fate conversion4–8. Reprogramming-capable
TFs originate from diverse structural families without any
obvious evolutionary relationship, and even closely related factors
can vary widely in their reprogramming competency. Repro-
gramming capability is a function of special molecular features on
TFs, but what these features are remains poorly understood
(reviewed in ref. 9 and ref. 10). For example, the reprogramming
function of Sox2 and Oct4 appears to rely on subtle molecular
underpinnings. Replacing Sox2 with other Sox factors such as
Sox4, Sox7, or Sox17 obliterates the activity of reprogramming
cocktails11,12. Similarly, Oct4 cannot be replaced by other para-
logous POU (Pit-Oct-Unc) family members such as Oct6, Oct1,
or Brn4 in standard retroviral reprogramming systems12–15.
Further, Oct6 cannot substitute for Oct4 in a pluripotency
maintenance assay14,16. POU III family members (Oct6, Brn2,
Brn4) were used to transdifferentiate ﬁbroblasts to post-mitotic
neurons or neural progenitor cells3,17–19. Brn2 was reported to be
unable to bind closed-chromatin in neural reprogramming20
whilst Oct4 was regarded as a pioneer factor that can bind and
possibly open up closed chromatin in human pluripotency
reprogramming21. This suggests that at least one of the unique
molecular features of reprogramming-competent versus incom-
petent factors is their ability to reconﬁgure chromatin.
We and others have begun to unravel the molecular basis for
the disparate functions of Oct4 and Oct613,14,16,22,23. As
monomers, POU factors target the octameric ATGCAAAT
consensus binding sites. Longer and more speciﬁc sequences
can be targeted through DNA-dependent dimer formation
with partner factors. For example, Oct4 pairs with Sox2 to bind
the canonical SoxOct motif24 or with Sox17 to bind the com-
pressed SoxOct motif25–27. The interference with Oct4-Sox2
association by mutations that perturb the heterodimer inter-
face abolishes reprogramming (Oct4I21Y/D29R, henceforth
termed Oct4defSox2)14,24,28 (Fig. 1a). Conversely, mutations in
Sox7 and Sox17, that facilitate the interaction with Oct4 on the
canonical SoxOct DNA element and reduce binding to the
compressed SoxOct element, enable highly efﬁcient
reprogramming11,25,26,29. Homodimeric DNA recognition by
POU factors is facilitated by the Palindromic Octamer
Recognition Element (PORE, ATTTGAAATGCAAAT)30 and
the More-palindromic Octamer Recognition Element (MORE,
ATGCATATGCAT)31,32. Oct4 has a preference to form het-
erodimers with Sox2 on the canonical SoxOct element whilst
Oct6 preferentially homodimerises on the MORE element14
(Fig. 1a). The MORE element has been associated with gene
regulation in neural lineages by Oct6 and Brn222. Modifying
the interface that mediates binding of Oct6 to MORE con-
tributes to the conversion of Oct6 into a pluripotency inducing
factor but only if additional modiﬁcation to the Sox2 interac-
tion interface are introduced as well14. Together, molecular
differences that set Oct6 and Oct4 apart have been character-
ized biochemically and functionally but how these differences
affect gene regulation, chromatin binding and chromatin
dynamics has remained unclear. To address this, we performed
genome-wide analyses of Oct4, Oct6, and Oct4defSox2 during
somatic cell reprogramming to pluripotency.
We ﬁnd that reprogramming cocktails with POU (Oct4-SK,
Oct6-SK, and Oct4defSox2-SK) and without POU factor (GFP-SK)
can silence somatic genes but only the Oct4-SK cocktail can
activate the pluripotency network. Although Oct6 binds to
different sites than Oct4 during reprogramming, the Oct6-SK
cocktail induces widespread chromatin opening including at Oct4
bound sites. Conversely, Oct4defSox2 mostly targets a similar set of
sites as Oct4 but interferes with the chromatin opening activity of
Sox2 at Oct4-Sox2 co-bound sites containing SoxOct motifs. The
presence of Sox2 in the reprogramming cocktail appears to be
sufﬁcient for bringing about most chromatin changes at the initial
stages of reprogramming; whereas at later stage, the lineage
safeguarding role of cooperative Oct4/Sox2 heterodimers is cru-
cial to complete reprogramming.
Results
Oct4 is dispensable for somatic silencing. To understand the
unique role of Oct4 at different stages of somatic cell repro-
gramming, we ﬁrst studied reprogramming outcomes and the
gene expression dynamics. To minimize the heterogeneity of the
analyzed cell populations, we used chemically deﬁned iCD1
medium, three factor OSK (Oct4-Sox2-Klf4) cocktail33 and
mouse embryonic ﬁbroblasts harboring an Oct4-GFP reporter
(OG2-MEFs; referred to as MEFs hereafter)34 (Fig. 1b). Under
these conditions, about 8–10% of the plated MEFs reprogram in a
highly synchronous manner giving rise to Oct4-GFP-positive and
Nanog-positive colonies within 7 days (Fig. 1c, Supplementary
Fig. 1A-B). iPSC lines derived with this system show a high rate of
contribution to chimeric mice and germline transmission33,35.
The cells pass through the MET (mesenchymal to epithelial
transition)36,37 at days 1–2 and the transgenic OG2 reporter is
activated at day 3–4 (Supplementary Fig. 1A).
We compared cocktails expressing Oct4 with that of Oct6 and
an Oct4defSox2 mutant that is incapable to co-bind Sox2 on
composite SoxOct DNA elements14,24. Both Oct6-SK and
Oct4defSox2-SK cocktails cannot generate GFP positive (GFP+)
colonies in chemically deﬁned medium (Fig. 1d) similar to serum/
LIF conditions14. We next measured gene expression using bulk
RNA-sequencing from MEFs (prior to reprogramming) and
reprogramming cell intermediates at days 0, 1, 3, 5, and 8. We
also included a POU-free control where Oct4 was replaced by
retroviruses expressing GFP in a GFP-SK cocktail. At day 0, each
cocktail showed nearly identical expression proﬁles that still
clusters with the starting MEFs (MEF-like, Fig. 1e, Supplementary
Fig. 1C). At day 1, the expression proﬁles remain similar for the
four conditions but are distinct from MEFs.
At days 3 and 5 bulk expression proﬁles remain rather similar,
however, by day 8, the expression proﬁle of Oct4-SK is distinct
from the other TF cocktails, and is closest to pluripotent cells
(Fig. 1e, Supplementary Fig. 1C-D, Supplementary Table 1).
RNA-seq was performed using unsorted cells explaining why day
8 Oct4-SK samples still show some differences to more
homogeneous iPSC/ESC samples. Expression proﬁles for cells
transfected with reprogramming incompetent POUs are similar
at days 5 and 8 (Fig. 1e, Supplementary Fig. 1C). In all conditions,
we observed a gradual loss of MEF identity (Fig. 1f, Supplemen-
tary Fig. 1E). However, Oct4defSox2-SK, Oct6-SK, and GFP-SK
conditions fail to activate early and late pluripotency genes. In the
Oct6-SK condition, the activation of epithelial genes such as Cdh1
(encoding E-cadherin) is impeded. FACS analysis conﬁrmed that
from days 3–8 less than 20% of cells were E-cadherin positive in
the Oct6-SK condition compared to 89% in Oct4-SK condition
(Fig. 1g, Supplementary Fig. 2A–C). At days 3 and 5, E-cadherin
levels in the Oct6-SK condition were even lower than in the
conditions lacking POU factors (GFP-SK and SK conditions).
Differential gene expression analysis using the GFP-SK condition
as a reference showed a larger number of differentially expressed
genes in the Oct4-SK condition by day 8 than for Oct6-SK
and Oct4defSox2-SK conditions (Supplementary Fig. 2D-E,
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Supplementary Data 1). The upregulated genes in Oct4-SK at day
8 showed gene ontology terms enriched for embryo development,
meiosis, blastocyst formation and DNA (de)methylation (Sup-
plementary Fig. 2F). The set of genes upregulated by Oct6-SK
showed enrichment of terms associated with somatic system
development (e.g., circulatory and neuronal systems). Collec-
tively, our data suggest that transcriptional responses at early
stages of reprogramming do not require Oct4 but the induction of
pluripotency genes are crucially dependent on Oct4, and related
POU factors cannot substitute for this function.
Cis-regulatory dynamics of Oct4 during reprogramming. To
link the expression proﬁles to genome occupancy, we performed
ChIP-seq (Supplementary Fig. 3A-B, Supplementary Tables 2–3)
and proﬁled the binding pattern of Oct4 at days 1, 5, and 7. We
deﬁned 7 trajectory groups (abbreviated with digits marking
presence (1) or absence (0) of binding at days 1, 5, and 7) (Fig. 2a,
Supplementary Data 2). De novo motif discovery on each tra-
jectory group detected four types of POU motifs: the octamer; the
composite SoxOct element; the palindromic MORE anda MORE
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(100, 010) are devoid of any detectable composite POU motif and
showed a stronger enrichment for somatic motifs potentially
reﬂecting binding within accessible somatic enhancers
(Fig. 2b–d). MORE motifs are most abundant at locations that are
targeted early and remain occupied at subsequent time points
(110, 111), whereas they are depleted in sites that are exclusively
bound in the late stage (‘001’). SoxOct motifs are enriched in
locations occupied at late stages regardless of their binding pat-
tern at earlier time points (Fig. 2b–e). Collectively, these analyses
suggest that genome-wide Oct4 binding is dynamic (Fig. 2f,
Supplementary Table 4), however the presence of MORE and
SoxOct elements is associated with more persistent binding. To
test whether MORE sites also possess enhancer activity, we
selected two genomic sequences near the Sox21 and Spata13
genes that are constitutively bound by Oct4 and showed pro-
gressively increasing expression during reprogramming
(Fig. 2g–h). First, we performed an EMSA (electrophoretic
mobility shift assay) using probes with composite MORE (near
Spata13) and SoxOct (near Sox21) elements (Fig. 2i, Supple-
mentary Table 5). Oct4 binds the MORESpata13 but homodimer
bands are only observed at high protein concentration suggestive
of low homodimer cooperativity as reported previously for other
MORE-like elements14. In contrast, on SoxOctSox21 DNA Oct4/
Sox2 heterodimer bands predominate over monomeric bands
indicating positive cooperativity (Fig. 2i). Both SoxOctSox21 and
MORESpata13 sequences activated the expression of a GFP-
reporter in mouse ESCs in a STARR-reporter assay38 (Fig. 2j,
Supplementary Tables 6–8). This activation was signiﬁcantly
reduced upon mutation of these DNA motifs indicating that both
motif sequences are capable of mediating enhancer activity in
ESCs. In summary, Oct4 binds chromatin dynamically using
different motif signatures at different stages and predominantly
acts as transcriptional activator.
Switching MORE binding with a point mutation. We had
previously identiﬁed an amino acid at position 151 of the Oct4-
POU which governs that Oct4 homodimerises less cooperatively
than Oct6 on MORE DNA14. Exchanging this residue by gen-
erating mutant Oct4S151M and Oct6M151S proteins strongly
increases homodimerisation for Oct4 and decreases homo-
dimerisation for Oct614. In four-factor (4F, OSKM) serum/LIF
conditions the Oct6M151S mutation combined with mutations at
the Sox2 interaction surface and the linker converts Oct6 into a
pluripotency inducer14. To test whether the switch in motif
preferences also occurs in a chromatin context, we performed
ChIP-seq for Oct4S151M (Oct4SM) and Oct6M151S (Oct6MS) at
day 1. Indeed, Oct4S151M shows an increased preference for
MORE and MORE+ 1 motifs (Supplementary Fig. 3C-F). Con-
versely, Oct6M151S loses its preference for the MORE element
compared to Oct6. Yet, Oct6M151S does not show a marked gain
in binding at SoxOct elements, in line with its inability to induce
pluripotency (Supplementary Fig. 3G). In the 4 F serum/LIF
condition, we previously found that Oct4S151M reduces the iPSC
colony yield to ~70% of that of Oct414. In the 3 F iCD1 system
used here, the iPSCs colony yield for Oct4S151M is reduced
compared to Oct4 at day 4 but is similar at day 7 (Supplementary
Fig. 3H). Accordingly, despite the binding to many MORE sites
not targeted by Oct4, Oct4S151M remains bound to the critical set
of Oct4 sites containing SoxOct motifs (Supplementary Fig. 3I).
Oct4, Oct6, and Oct4defSox2 show different motif preferences.
To explore the properties that endow Oct4 with the capacity to
reprogram, we contrasted its binding proﬁle with that of Oct6 and
Oct4defSox2 by ChIP-seq at days 1 and 5. All three exogenous
POU constructs were expressed at comparable mRNA levels
(Supplementary Fig. 4A, Supplementary Table 9). However
expression of endogenous Oct4 was only activated by the Oct4-
SK cocktail. Oct4, Oct6, and Oct4defSox2 proteins were mainly
present in the nuclear fraction with highest levels at day 1 fol-
lowed by a moderate decrease over the subsequent days especially
for Oct6 and Oct4defSox2 (Supplementary Fig. 4B). The binding
pattern of Oct4 at day 1 observed in this study correlates with
previously reported early stages for secondary-mouse/Serum/LIF
conditions, where cells reprogram slowly4–6 (Fig. 3a). Oct4
binding at days 5 and 7 correlates with the maturation and pre-
iPSCs stages in these systems4,5. Oct6 targets a unique set of
genomic locations from the onset of its ectopic expression with
only weak signals at sites occupied by Oct4 throughout the
pluripotency reprogramming. Oct6 binding also does not corre-
late with POU III factors binding during neural
reprogramming18,20,22,39 (Fig. 3b–c, Supplementary Fig. 4C-D).
The occupancy of Oct4defSox2 correlates with Oct4 at day 1, but
not at day 5 (Fig. 3a–c). Overlap of Sox2 binding in the respective
conditions was only moderate with more uniquely bound than
shared sites (Supplementary Fig. 4E-F). Motif analysis revealed
that the canonical SoxOct element predominates in locations
occupied by Oct4 and its fraction increases at the late stage
(Fig. 3d–f). Surprisingly, Oct4defSox2 also shows enrichment for
the SoxOct motif at day 1, but at day 5 the MORE motif pre-
dominates, suggesting that Oct4defSox2 can bind to composite
SoxOct DNA. Oct6 preferentially targets MORE locations at both
time points. Taken together, we found that the initial binding
proﬁle of Oct4defSox2 resembles Oct4 whilst Oct6 binds a different
set of locations, raising the question as to how these different
binding landscapes correlate with chromatin state transitions.
The Oct6-SK cocktail retains the capacity to open chromatin.
Three studies reported that Oct4 preferentially targets closed
chromatin when reprogramming is initiated supporting the view
that it acts as pioneer factor6–8. Work by two other laboratories
concluded that Oct4 is directed to pre-opened and active
Fig. 1 Reprogramming trajectories of cocktails containing Oct4, Oct6, Oct4defSox2, or GFP in chemically deﬁned medium. a The cartoons represent the
preferences of the POU proteins for the DNA-dependent homodimerization on MORE versus heterodimerization with Sox2 on SoxOct elements
determined using quantitative biochemical assays14. MORE DNA is shown in orange and SoxOct DNA in blue; m1 is monomer 1 and m2 is monomer2. The
thickness of the arrows illustrates the DNA binding preferences. b Experimental design of reprogramming and RNA-seq, ATAC-seq, and ChIP-seq
experiments. c Whole-well scans from a 6-well plate using GFP channel (Oct4-GFP), Nanog immunoﬂuorescence and merged panels; for OG2-MEF cells
reprogrammed with Oct4-SK at day 8; scale 5 mm. d Whole-well scans (upper panel) of wells from 12-well plate using GFP channel for three POU factors
(Oct4, Oct4defSox2, and Oct6); scale 5 mm. Representative phase contrast (middle panel) and corresponding Oct4-GFP ﬂuorescence (lower panel) images
of reprogramming experiments; time-point: day 8 post transduction; scale 200 μm. e Hierarchically clustered heatmap based on r2 correlation coefﬁcients
using RNA-seq reads as input. iPSCs and ESCs expression data are from GSE9302942. f Mean gene expression trajectories for indicated categories (upper
panel) or a representative gene from each category (lower panel) in four reprogramming conditions. See Supplementary Fig. 1E for a larger panel of genes
for each category. g Fraction of E-cadherin positive (Cdh1+ ve) cells at different stages of reprogramming in indicated cocktails. FACS was performed in
technical duplicates (n= 2). Source data for FACS experiment are provided as a Source Data ﬁle
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Fig. 2 Determinants for the binding trajectories of Oct4. a Heatmap of Oct4 ChIP-seq signal within 2 kb window centered at Oct4 summits. Rows are Oct4
peaks arranged in 7 binary trajectories. 1 indicates presence and 0 absence of binding; left to right digits are days 1, 5 and 7. Summits were merged if within
100 bp. Genomic locations are provided in Supplementary Data 2. b Enrichment of selected TF motifs in Oct4 occupancy trajectories. Point size represents
the proportion of sequences with the motif and color gradient (blue to red) the p-value score. c Consensus binding motifs of Oct4 represented as PWMs
(position weight matrices). POU binding sites are underlined. d Proportion of ChIP-seq peaks in each occupancy trajectory featuring ‘any’ (consensus
motifs shown in c) or ‘none’ of these POU motifs. e Fraction of binding locations for each occupancy trajectory containing the indicated POU motifs. ‘All’
refers to peaks where motif scanning concurrently detected all the POU motifs listed in (c) and ‘none’ the absence of any of these motifs. f Genome
browser track of Oct4 ChIP-seq peaks (shaded gray) for selected trajectories. Genomic coordinates for the summits are listed in Supplementary Table 4.
g Genome browser tracks of constitutively bound Oct4 and Sox2 ChIP-seq peaks containing either SoxOct (near Sox21 gene) or MORE (near Spata13 gene)
motifs. h Gene expression (mean tag counts as bar and individual technical replicate as dots) of Sox21 and Spata13 in the Oct4 condition. i EMSAs using
Oct4-POU and Sox2-HMG protein constructs and DNA probes containing SoxOct elements (near the Sox21 gene) or MORE elements (near the Spata13
gene). EMSA probes are provided in Supplementary Table 5. j STARR reporter assay38 in ESCs with Oct4 bound regions from (g) near Sox21 or Spata13.
The positive and negative control sequences are shown in Supplementary Table 8. Each data point (n= 4, biological replicates) is shown with mean as
black bar; indicated p-values were calculated by Student’s t-test. Source data for i and j are provided as a Source Data ﬁle
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enhancer controlling somatic genes4,5. To resolve these alter-
native views, we probed chromatin accessibility by ATAC-seq
(assay for transposase-accessible chromatin using sequencing)40
with Oct4-SK, Oct6-SK, and Oct4defS2-SK cocktails at days 1 and
5 of reprogramming (Supplementary Fig. 5A). We used chrom-
VAR41 to test whether particular TF motifs are associated with
variations in chromatin accessibility across Oct4-SK, Oct6-SK,
and Oct4defS2-SK samples (Supplementary Fig. 5B). We found
that the sites with canonical SoxOct motifs show an increased
accessibility in Oct4-SK and Oct6-SK conditions at days 1 and 5
compared to MEFs, but not in the Oct4defSox2-SK condition
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Fig. 3 POU TFs exhibit distinctive binding proﬁles and motif preferences. a Hierarchical clustering of the pairwise correlation coefﬁcients (R2) of ChIP-seq
signals from Oct4, Oct4defSox2 and Oct6 ChIP-seq peaks with publically available ChIP-seq datasets for Oct4, Oct6 and Brn24–6,18,20,22,39,69. b ChIP-seq
signal heatmaps for Oct4 (green), Oct4defSox2 (orange), and Oct6 (salmon) at days 1 (left panels) and 5 (right panels) centered on ChIP-seq peaks for
Oct4 (top panels), Oct4defSox2 (middle panels) and Oct6 (bottom panels). c Boxplots of quantile normalized ChIP-seq signals at Oct4, Oct4defSox2 and
Oct6 peaks at days 1 and 5 from heatmaps in (b). For the boxplots, the midline indicates the median, boxes indicate the upper and lower quartiles and the
whiskers indicate 1.5 times interquartile range. d Fraction of binding locations containing MORE (including MORE variant with 1 bp spacer) or SoxOct
elements at different reprogramming stages. ‘Both’ refers to peaks where motif scanning detected MORE and SoxOct motifs concurrently and ‘none’ the
absence of either of the two motifs. e Enrichment of selected TF motifs in ChIP-seq peaks at days 1 and 5 for Oct4, Oct4defSox2, and Oct6. Size represents
fractional occurrences and color gradient the p-value scores. f Top de novo motifs for Oct4, Oct4defSox2 and Oct6 at days 1 and 5. In the HOMER database
the MORE motif is designated as Pit1 and MORE+ 1 bp as Pit1+ 1bp70
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increased accessibility speciﬁcally in the Oct4defSox2-SK sample.
This suggests exogenous Sox2 or endogenously expressed Sox
factors might bind and open alternative genomic sites in the
Oct4defSox2-SK condition. Oct6-SK expressing cells show a spe-
ciﬁc increase in accessibility at sites marked by MORE and
octamer motifs (Fig. 4a). This suggests that the Oct6-SK cocktail
is not compromised in its ability to open chromatin.
In order to link chromatin accessibility changes to Oct4
binding, we divided Oct4 bound sites based on their chromatin
accessibility levels in MEFs (high, medium, and low, Fig. 4b). The
majority of Oct4 ChIP-seq peaks belong to the low accessibility
group (n= 5581) with good ChIP-seq signals suggesting that
Oct4 can effectively bind closed chromatin. The sites with low
and medium accessibility in MEFs became more accessible in
Oct4-SK and Oct6-SK conditions, but the increase in accessibility
is signiﬁcantly lower for the Oct4defSox2-SK condition. This is
inversely correlated with binding as the occupancy of Oct4defSox2
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occupancy levels are comparable at the sites with high
accessibility in MEFs among the three POU conditions, but it is
reduced at sites with low accessibility in MEFs in the Oct4defSox2
condition (Supplementary Fig. 5C).
Collectively, our data support a view that Oct4 pre-dominantly
binds to locations closed in MEFs rather than having a bias for
pre-opened MEF enhancers. Oct6-SK cocktails retain the ability
to bring about chromatin accessibility changes at Oct4 bound
sites and loci marked with SoxOct motifs whilst this activity is
mitigated in the Oct4defSox2-SK condition.
Sox2 directs chromatin opening augmented by Oct4. We next
asked whether Sox2 or Oct4 is more potent at facilitating chro-
matin opening. To address this, we used ATAC-seq data in MEFs
and at day 1 in the Oct4-SK condition and deﬁned sites that
undergo closed-to-open (CO) transition (Fig. 4c–d). We next
deﬁned CO locations co-bound by Oct4 and Sox2 or only bound
by one of the factors (Fig. 4c–e). We found a signiﬁcantly stronger
increase in accessibility at sites bound by Sox2-only compared to
sites bound by Oct4-only (Fig. 4e). Yet, the increase in accessi-
bility was most profound in Oct4/Sox2-shared sites. To verify this
ﬁnding, we downloaded publicly available ATAC-seq data where
Sox2 and Oct4 were overexpressed alone or in pairs by two dif-
ferent laboratories5,42. Data from both studies revealed a stronger
increase in chromatin accessibility when Sox2 is expressed alone
(S) as compared to Oct4 alone (O) expression. We performed an
analogous analysis with data from the Oct4defSox2-SK condition
and observed a stronger ATAC-seq signal for Sox2 only over
Oct4defSox2-only bound sites and a further elevated accessibility at
Oct4defSox2/Sox2-shared sites (Supplementary Fig. 5D–F). Thus,
we conclude that Sox2 appears to be a better facilitator of chro-
matin accessibility changes than Oct4. Nevertheless, Oct4 aug-
ments chromatin opening concurrently with Sox2.
Oct4defSox2 impedes chromatin opening at SoxOct motifs. We
next sought to uncover differences between Oct4/Sox2 and
Oct4defSox2/Sox2 co-bound locations. Accessibility changes at
Oct4/Sox2-shared and Oct4defSox2/Sox2-shared sites correlate
with binding in the two samples indicative of a direct causal
relationship between binding and an increase in accessibility
(Fig. 4f). Oct4defSox2 (but not co-expressed Sox2) remains bound
at Oct4/Sox2-shared sites and Sox2 (but not co-expressed Oct4)
remains bound at Oct4defSox2/Sox2-shared sites (Fig. 4f). The
overlap between co-bound Oct4defSox2/Sox2 and Oct4/Sox2
locations is low (Fig. 4g). Oct4defSox2 has been designed to inhibit
DNA-dependent heterodimerisation with Sox2 in the context of
canonical SoxOct element, but not when the half-sites are
arranged differently (i.e., if the spacing is increased24). Con-
sistently, motif analysis revealed that only 10% of Oct4defSox2/
Sox2-shared locations have matches to the canonical SoxOct
motif compared to 40% Oct4/Sox2 co-bound locations (Fig. 4h).
This suggests that Oct4defSox2 interferes with Sox2 mediated
chromatin binding and opening in the context of the SoxOct
motif (Fig. 4i).
To further test this hypothesis, we ﬁrst categorized genomic
locations according to occupancy patterns using ChIP-seq peaks
for Oct4, Oct4defSox2, and Sox2 at day 1 and then inspected
ATAC signals at day 1 across these categories (Supplementary
Fig. 6A–C). We found elevated chromatin accessibility at sites
bound by Sox2 compared to sites where it is not bound
(Supplementary Fig. 6B–D). At sites co-bound by Oct4 and
Oct4defSox2, the ATAC-seq signal is stronger in the Oct4
condition compared to the Oct4defSox2 condition whether or
not Sox2 is present. Second, we inspected sites with a putative role
in pluripotent cells and deﬁned Oct4 bound sites that are closed
in MEFs but open in ESCs. We split this set into sites with
matches to the canonical SoxOct motif and sites lacking SoxOct
motif (Supplementary Fig. 7A). We found ﬁnd that opening at
these sites is compromised in the Oct4defSox2 condition in the
subset of sites with SoxOct motifs (Supplementary Fig. 7A–B). At
sites lacking SoxOct motifs, the difference in opening between
Oct4 and Oct4defSox2 conditions is less profound. Singly
expressed Sox2 (S) shows a stronger accessibility increase than
singly expressed Oct4 (O) or Klf4 (K) at sites with and without
SoxOct motifs. The combination of Sox2 and Oct4 (OS) markedly
increased accessibility (Supplementary Fig. 7A–D).
Sites with SoxOct motifs are most likely critical for conducive
reprogramming. Oct4defSox2 targets SoxOct sites and mitigates
accessibility changes facilitated by Sox2 at these locations, but not
at alternative sites with a different cis-regulatory architecture
(Fig. 4i). In contrast, Oct6-SK opens SoxOct locations reminis-
cent to Oct4-SK and differences only become apparent for a
subset of pluripotency enhancers at later reprogramming stages
(Supplementary Fig. 7E–G).
Oct4/Sox2 heterodimers are critical for persistent binding. We
further asked if the DNA motifs affect the initial Oct4/Oct4defSox2
recruitment and persistence of binding. Oct4defSox2 binds to
many SoxOct sites also bound by Oct4 at day 1 (Fig. 2a, Sup-
plementary Fig. 8A). We focused on sites constitutively bound by
Oct4 (110, 111) and observed that Oct4defSox2 effectively targets
Fig. 4 Sox2 facilitates chromatin opening and Oct4 augments it. a Accessibility variation of ATAC-seq peaks categorized by the presence of selected motifs
was determined by chromVAR. Data are scaled row-wise. The color gradient denotes high (red) and low (blue) accessibility. n= number of ATAC-seq
peaks containing indicated motifs. b Oct4 ChIP-seq peaks at day 1 were ranked by ATAC-seq read coverage in MEFs and grouped into sites with high (read
counts > 30, n= 1490), medium (read counts= 15 to 30, n= 1145) and low-accessibility in MEFs (read counts < 15, n= 5581). Box plots show ATAC-seq
and POU ChIP-seq signals at peaks from three corresponding groups. c Analysis ﬂow chart to interrogate the role of Oct4 and Sox2 in facilitating chromatin
opening. d ATAC-seq signal heatmaps grouped by three chromatin trajectories: PO (permanently open), OC (open to close), CO (close to open) deﬁned
using ATAC-seq peaks from MEFs (GSE9302942) and the Oct4-SK day 1 condition. Numbers indicate peak numbers. e The CO category was further
grouped by the presence of Sox2 and Oct4 ChIP-seq peaks from day 1Oct4-SK condition. ChIP-seq and ATAC-seq signal heatmaps were generated using
data from this study and indicated sources. Boxplots represent the day1 by MEF ATAC-seq signal ratio. f Heatmaps showing the ChIP-seq (left) and ATAC-
seq (right) signals at ChIP-seq peaks deﬁned by co-binding of Oct4/Sox2 or Oct4defSox2/Sox2. Boxplots are day 1/MEF ATAC-signal ratios over the two
peak sets. g Overlap of Oct4/Sox2 and Oct4defSox2/Sox2 ChIP-seq peaks. h Fraction of Oct4/Sox2 and Oct4defSox2/Sox2 peaks with matches to the
canonical SoxOct motif. i Oct4defSox2 prevents Sox2 from targeting sites with canonical SoxOct elements whilst co-binding of Oct4defSox2/Sox2 at
alternative locations is permitted. The size of spheres schematically represent binding preferences. p-values in b and e were calculated using the unpaired
Wilcoxon rank sum test (R function pairwise.wilcox.test) adjusted for multiple testing using the Holm method. ATAC-seq boxplots show signals
normalized using EAseq (DNA fragments per kilobase pairs (kbp) per million (m) reads) and POU ChIP-seq read coverage boxplots were quantile
normalized. Genomic locations for b, d, e, and f are provided in Supplementary Data 2. For the boxplots, the midline indicates the median, boxes indicate
the upper and lower quartiles and the whiskers indicate 1.5 times interquartile range
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Fig. 5 Oct4defSox2 targets pluripotency enhancers but eventually derails. a Heat maps of ChIP-seq reads at days 1 and 5 for Oct4, Oct4defSox2 and Sox2 in
Oct4-SK (top panels) or Oct4defSox2-SK (bottom panels) cocktails centered at Oct4 constitutively bound occupancy trajectories (‘110’ and ‘111’) containing
SoxOct motifs (left panels) or MORE motifs (right panel). A cartoon on the left summarizes the results. b ChIP-seq reads at day 5 for Oct4 and Oct4defSox2
for Oct4 late bound occupancy trajectories ‘010’ and ‘011’ at SoxOct (top) or MORE (bottom) locations. c Heatmap of Oct4, Oct4defSox2 and Sox2 ChIP-seq
signals at days 1 and 5. Rows are Sox2 ChIP-seq peaks called in the Oct4-SK condition containing SoxOct motifs at day 1 (left panel) and day 5 (right
panel). ChIP-seq signal heatmaps in a, b and c are normalized using EAseq (DNA fragments per kilobase pairs (kbp) per million (M) reads) and shown for
2 kb genomic intervals centered on midpoints or motifs. d Genome browser tracks of selected Oct4, Oct4defSox2 and corresponding Sox2 ChIP-seq peaks
are shown at different days of reprogramming. The nearest genes and motif under the peaks are mentioned on the top. Genomic coordinates for the
summits are listed in Supplementary Table 4. e Phase-contrast images of conditional Oct4-knockout ZHBTc443 ESCs rescued with wild-type Oct4 or
Oct4defSox2 after culturing for 6 days in the presence of Dox (passage 1). Scale= 100 μm. f Fluorescence images of ZHBTc4 ESCs rescued with wild-type
Oct4 or Oct4defSox2 after 6 passages in the presence of Dox. Scale= 100 μm. The antibodies list is in Supplementary Table 11. g qRT-PCR analysis of
selected gene expression of ZHBTc4 ESCs rescued with wild-type Oct4 or Oct4defSox2 after 6 passages in the presence of Dox. The expression is relative
to untransduced control induced with Dox for 7 days. Rpl37a was used as a house keeping gene. Individual data points are shown as black jitter plots (n= 3,
technical replicates). The primers for Oct4 CDS (coding DNA sequence) and other markers are mentioned in Supplementary Table 10 and Source data are
provided as a Source Data ﬁle
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11054-7 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:3477 | https://doi.org/10.1038/s41467-019-11054-7 |www.nature.com/naturecommunications 9
them at day 1 regardless of motif signatures (Fig. 5a, Supple-
mentary Fig. 8B). However, by day 5 virtually all Oct4defSox2
binding to SoxOct sites is lost, whilst residual binding to MORE
sites persists (Fig. 5a). Sox2 effectively co-targets constitutively
bound SoxOct sites in the presence of Oct4 but not in the pre-
sence of Oct4defSox2 (Fig. 5a). Similarly, Oct4defSox2 is unable to
target SoxOct and sites devoid of POU motifs (none) in the Oct4
010 and 011 trajectories but retains some binding to MORE
locations (Fig. 5b, Supplementary Fig. 8C). We next explored the
occupancy of Oct4 and Oct4defSox2 at sites containing SoxOct
elements that were identiﬁed in Sox2 ChIP-seq data in Oct4-SK
condition at days 1 and 5 (Fig. 5c). At day 1, Oct4defSox2 effec-
tively occupies these sites whilst the signal for co-expressed Sox2
was depleted. Yet, at day 5 only Oct4 showed co-occupancy with
Sox2 in Oct4-SK condition but Oct4defSox2 was not bound at
these sites which now showed elevated signals for co-expressed
Sox2 (Fig. 5c–d). We conclude that early Oct4 binding does not
rely on heterodimer formation with Sox2, but it is critical for
persistent binding and recruitment to sites at later stages of
reprogramming.
Oct4 does not require co-bound Sox2 to maintain plur-
ipotency. To elucidate the importance of Oct4/Sox2 heterodimers
in the maintenance of pluripotency, we used ZHBTc4 ESC line
carrying an Oct4 transgene under the control of a tet-off pro-
moter43. The addition of Dox leads to the depletion of the Oct4
protein after 24 h and trophectodermal differentiation (Fig. 5e).
The exogenous introduction of Oct4 but not of Oct6 rescues
pluripotency14,16. Surprisingly, Oct4defSox2-expression could also
rescue the maintenance of pluripotency (Fig. 5e, Supplementary
Fig. 8D). ESCs expressing Oct4defSox2 could maintain high
expression levels of pluripotency markers, such as Sox2, Nanog,
Esrrb, and Rex1 even after 6 passages (Fig. 5f–g, Supplementary
Table 10) indicating that the Oct4-Sox2 interaction might not be
critical for pluripotency maintenance. However, in an analogous
assay for Sox2, Sox2 mutants deﬁcient in the DNA-dependent
dimerization with Oct4 cannot rescue pluripotency28. This sug-
gests that in the context of ESCs where Oct4 most likely binds
already accessible targets, Oct4 alone is able to maintain an
undifferentiated state. This is consistent with a report that Sox2
knockout ES cells could be rescued by the elevated expression of
Oct444. Oct4defSox2 showed a higher transgene expression than
cells expressing Oct4 (Fig. 5f–g). This indicates that in the
absence of Oct4-Sox2 dimers, Oct4defSox2 is required at a higher
dosage than Oct4 for pluripotency maintenance. Yet, Oct4defSox2
is a less potent suppressor of the trophectoderm lineage as indi-
cated by elevated Cdx2 expression and occasional Cdx2+ cells
(Fig. 5f–g). We conclude that Oct4 is more critical than Sox2 in
maintaining pluripotency and at elevated expression levels Oct4
alone can substitute for Oct4/Sox2 heterodimers.
Oct6 binds loci without enhancer activity in ESCs. To further
delineate the reason for the non-redundant functions of Oct4 and
Oct6, we deﬁned ﬁfteen occupancy groups for the binding pat-
terns of Oct4 and Oct6 at reprogramming days 1 and 5 (Fig. 6a,
Supplementary Data 2). Oct4 and Oct6 target a large set of
genomic locations that are not shared (1000, 0010 where the ﬁrst
two digits indicate Oct4 binding (1) or absence (0) at days 1 or 5
and last two digits absence/presence of Oct6). The set of sites
uniquely and transiently bound by Oct6 at individual days (0010,
0001) are depleted of known POU motifs but sites persistently
bond by Oct6 are enriched for MORE motifs (Fig. 6b).
We next compared the co-binding of Oct6 or Oct4 with Sox2
in exclusive binding categories (1000, 0010, 1100, and 0011) and
early shared binding (1010). Overall, Oct6 sites showed a weaker
signal for Sox2 occupancy than Oct4 sites (Supplementary
Fig. 9A) except for a subset of sites shared by both Oct4 and
Oct6 at day 1 of binding (1010; Supplementary Fig. 9A). Sox2
peaks with matches to SoxOct motifs (when co-expressed with
Oct4 or Oct6), had stronger Oct4 signals than Oct6 (Supple-
mentary Fig. 9B–C).
In order to identify enhancers in ESCs, we performed STARR-
seq (Self-transcribing active regulatory region sequencing)38 assay
containing regions of open chromatin isolated by formaldehyde-
assisted isolation of regulatory elements (FAIRE)45. The STARR-
input library showed a good correlation with DNase-seq (DNase I
hypersensitive sites sequencing) performed in E14 ESCs46 with
59% overlapping peaks (Supplementary Fig. 9D-E). The analysis
for the overlap between STARR-seq regions occupied by Oct4 in
ESC shows that around 50% (18,066) of Oct4 bound sites are
covered by the STARR-input library and 1940 (11%) of these
showed an overlap with active STARR-seq enhancers (Supple-
mentary Fig. 9F).
We next analyzed the ESC enhancer activity of loci bound by
Oct4 and Oct6 at days 1 and 5 containing either SoxOct or
MORE motifs. We found that the representation in the STARR-
seq library was higher for Oct4 bound regions (18% at day 1, 30%
at day 5) than for Oct6 bound regions (9 and 14% for days 1 and
5, respectively; Supplementary Fig. 9G-H). Moreover, for Oct4
bound regions covered by the STARR-seq library, we found
robust enhancer activity for SoxOct motifs and lower activity for
MORE motifs (Fig. 6c, Supplementary Fig. 9H). The enhancer
activity was highest for sites occupied at day 5, when cells
gradually become more similar to ESCs. In contrast, Oct6 bound
regions represented in the STARR-seq library are virtually devoid
of enhancer activity, indicating that most of the Oct6 binding
does not occur at ESCs enhancers. Despite the similar ability of
Oct4-SK and Oct6-SK conditions to open chromatin, the
genomic binding proﬁles of Oct4 and Oct6 are different. Oct6
binds regulatory regions that are not required for reprogramming
and are without enhancer activity in ESCs.
Discussion
In this study, we dissected the temporal dependencies of plur-
ipotency reprogramming on chromatin binding, opening and
gene regulation by Sox2 and Oct4. To gain detailed molecular
insights into this process, we collected reference data by replacing
Oct4 with two incapacitated POU factors, Oct6 and Oct4defSox2.
At day 1, the binding proﬁle of Oct6 is distinct from Oct4 whilst
accessibility changes particularly at Oct4-bound sites are similar
(Fig. 6d). Yet the binding proﬁle of the mutant Oct4defSox2
resembles Oct4 but chromatin opening at SoxOct motifs is
hampered. Sites with increased accessibility in the Oct4defSox2-SK
condition are enriched for single (non-composite) Sox motifs.
This suggests that Oct4defSox2 impedes accessibility changes in the
context of the composite SoxOct element but it does not inhibit
opening per se. Rather, Oct4defSox2 perturbs the sequence of
chromatin dynamics by interfering with Sox2 binding (or binding
by endogenous Sox factors) on SoxOct elements. This might in
turn cause Sox factors to bind ectopic sites. Sox2 alone can
facilitate chromatin opening but Oct4 by itself has a limited
potency to bring about accessibility changes (Fig. 4e). However,
Oct4 can augment the chromatin opening by Sox2. Likewise,
Oct4 binds to only a small fraction of active ESC enhancers at
days 1 and 5 of reprogramming. This indicates that Oct4 does not
engage pluripotency genes on-target and could explain why iPSC
generation is rather slow and inefﬁcient. Surprisingly, Oct4/Sox2
dimerization does not appear to be required for the initial target
search of Oct4. Oct4defSox2 can occupy many genomic locations
similar to Oct4 at the onset of reprogramming (Fig. 3b).
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Evidently, Oct4defSox2 is permitting transcriptional responses and
exhibits binding patterns that correlate with aspects of Oct4-
driven reprogramming. The uniqueness of Oct4 becomes evident
at later stages of reprogramming. Due to its inability to partner
with Sox2; Oct4defSox2 will eventually fail to induce pluripotency
(Fig. 6d). The dependence of the activation of the pluripotency
network on Oct4/Sox2 heterodimers suggests that this hetero-
dimer fulﬁlls a role analogous to a lineage guardian without which
faithful lineage speciﬁcation from a plastic intermediary state
cannot occur47. Whilst Oct4defSox2 is incapable of inducing
pluripotency, it was still found to retain the ability to maintain
pluripotency. This indicates that the Oct4/Sox2 partnership is
more important to induce the pluripotency than for its
maintenance.
In the Oct6-SK condition, we observed an increased accessi-
bility at ATAC-seq peaks marked by MORE or octamer motifs
(Fig. 4a). Apparently, in addition to permitting opening at peaks
containing SoxOct elements reminiscent to the Oct4-SK condi-
tions, the Oct6-SK condition leads to additional opening pre-
sumably by the direct binding of Oct6. Therefore, our study does
not support a model whereby Oct4 acquired unique features
enabling it to act as pioneer factor in comparison to Oct6. Bulk
gene expression proﬁles suggest that Oct4 is not required to
silence somatic genes. The initial gene expression response
appeared rather similar for all tested cocktails with one notable
exception. Oct6-SK appears to counteract epithelialization
demonstrated by a muted upregulation of E-cadherin compared
even to the two-factor SK conditions. As Oct6 mostly vacates
Oct4 bound regions and prefers alternative binding elements
(MORE) it is unlikely that it directly antagonizes Klf4, the key
driver of the epithelial program36,48. We surmise that the
restriction of the MET by Oct6 occurs indirectly through path-
ways that remain to be uncovered rather than by a direct com-
petition with Klf4.
We show that Sox2 is critical for facilitating chromatin state
changes, Oct4-Sox2 heterodimers are essential for the activation of
pluripotency genes and Oct4 is the key factor for pluripotency
maintenance (Fig. 6d). The initial cellular response to the over-
expression of exogenous TFs appears to be dominated by binding
that is not directly associated with reprogramming. Subtle mod-
iﬁcations to the factor composition and speciﬁc mutations to
reprogramming TFs can lead to drastically different outcomes of
reprogramming experiments. We envisage this insight can be
exploited to re-design TFs by protein engineering to improve
reprogramming, transdifferentiation and forward programming for
the fast and efﬁcient generation of cells for regenerative medicine49.
Understanding the sequence-structure-function relationships of
reprogramming factors could enable to devise “one for all” factor
libraries that would allow to screen and select a suitable mix of
engineered TFs for any donor-target cell combination.
Methods
Cell lines and culture conditions. Mouse embryonic ﬁbroblasts (OG2-MEFs,
Jackson laboratory, #004654) derived from E13.5 embryos carrying the Oct4






































































































Fig. 6 Oct6 binds to alternative targets and avoids pluripotency enhancers. a Comparison of Oct4 (green color) and Oct6 (salmon color) ChIP-seq signals
at days 1 and 5 of reprogramming. Rows are 15 occupancy trajectories deﬁned by the presence or absence of Oct4 or Oct6 peaks at day 1 or 5 (1= binding,
0= absence of binding). The summits were merged if they were within 100 bp. Genomic locations are provided in Supplementary Data 2. b Fraction of
POU motifs mapping to binding sites in each of the occupancy trajectories. c Read pileup plots of STARR-seq signal (enhancer activity) in ESCs at Oct4
(left) and Oct6 (right) binding sites at days 1 (up) and 5 (bottom) of reprogramming containing either SoxOct or MORE motifs. d Model for unique and
dispensable roles of Oct4 at different stages of somatic cell reprogramming
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promoter driven GFP transgenic allele34,50 were obtained from the core animal
facility at GIBH. Animal care and experimental protocols were approved by the
Guangzhou Institutes of Biomedicine and Health Ethical Committee. OG2-MEFs
were maintained in high glucose Dulbecco’s modiﬁed Eagle’s medium (DMEM
4.5 g per L D-glucose, Thermo Fischer Scientiﬁc) supplemented with 10% fetal
bovine serum (FBS, Natocor, #SFBE), 1× GlutaMax (Thermo Fischer Scientiﬁc
#35050061), non-essential amino acids (1× NEAA, Thermo Fischer Scientiﬁc,
#11140050). Retrovirus producing Plat-E cells51 were maintained in DMEM con-
taining 10% FBS. iPSCs were generated using the chemically deﬁned iCD1 med-
ium33. All the cells were cultured at 37 °C with 5% CO2.
Retrovirus infection and iPSCs induction. Retroviral infection was performed as
described33,42 with some modiﬁcations. Brieﬂy, Plat-E cells51 were seeded at 6–7 ×
106 cells per 100 mm dish and cultured overnight followed by incubation with
10 μg of each of the three individual pMX based retroviral vectors along with 40 μg
transfection reagent polyethyleneimine (PEI, Polysciences, #23966) dissolved in
1 mL Opti-MEM medium (Thermo Fischer Scientiﬁc, #31985070). Sox2 and Klf4,
as a part of 3-F cocktail, were common in all samples while the 3rd factor was Oct4,
Oct6, Oct4defSox2 (Oct4I21Y/D29R), Oct4S151M, Oct6M151S 14, or pMX-GFP. The
volume was adjusted to 10 mL with DMEM+ 10% FBS. The medium was changed
within 10–14 h with fresh DMEM supplemented with 10% FBS, 1× GlutaMax and
1× NEAA. Virus containing supernatants were collected after 48 and 72 h, cleared
with 0.45 μm ﬁlters (Millipore) and polybrene (Sigma, #40804ES76) was added to a
ﬁnal concentration of 8 μg per mL. OG2-MEF cells (3000–3500 cells per cm2) were
cultured in 12 well dishes and transduced with 0.5 mL viral supernatant or using
100 mm dishes and 6 mL of each viral supernatant. After two infections at an
interval of 24 h, the viral supernatants were replaced with iCD1 medium. The time
point of change into iCD1 medium was deﬁned as day 0 post-transduction (dpt).
The cells were imaged on a regular basis with Axio Vert A1 microscope (Zeiss) and
whole-well scans were taken at day 8 of reprogramming using an ImageXpress
Micro XLS confocal High-Content Imaging System (Molecular Devices).
Preparation of cytoplasmic and nuclear extracts. MEF cells and reprogramming
cells (3 × 106 cells) were collected by trypsinisation at 0, 1, 3, and 5 days post
transduction with retroviruses and washed twice with 1× PBS (Phosphate-buffered
saline, Thermo Fischer Scientiﬁc, #14200–075). The outer cell membranes were
lysed by incubation in 120 µL cytoplasmic extraction (CE) buffer (10 mM HEPES,
10 mM KCl, 0.1 mM EDTA, 1% IGEPAL CA-630, pH 7.9, freshly added protease
inhibitor cocktail) for 15 min on ice and periodical vortexing. The lysate was
centrifuged at 14,000 rpm for 5 min at 4 °C and the supernatant (cytoplasmic
fraction) was carefully transferred into a new micro-centrifuge tube. The remaining
pellet was washed once with CE wash buffer (10 mM HEPES, 10 mM KCl, 0.1 mM
EDTA) and subsequently resuspended and incubated in 120 µL nuclear extraction
(NE) buffer (20 mM HEPES, 0.4 M NaCl, 0.1 mM EDTA, 25% Glycerol, pH 7.9, 1%
SDS) for 40 min on ice, with vortexing every 10 min for 10 s. The lysate was
centrifuged at 14,000 rpm for 10 min at RT and the supernatant (nuclear fraction)
was transferred into a new micro-centrifuge tube.
Fluorescent western blot. Cytoplasmic and nuclear fractions of OG2-MEF cells
and reprogramming cells (Oct4, Oct6, and Oct4defSox2; each on days 0, 1, 3, and 5)
were used to perform western blots. SDS-PAGE sample loading buffer was
added and samples were heated for 5–10 min at 90 °C and loaded onto SDS-
polyacrylamide gel (stacking gel: 5% acrylamide, 125 mM Tris-HCl pH 6.8, 0.1%
SDS, 0.1% APS, 0.15% TEMED; resolving gel: 12% acrylamide, 390 mM Tris-HCl
pH 8.8, 0.1% SDS, 0.1% APS, 0.06% TEMED) and electrophoresed at 100 V for
120 min in SDS running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS). Transfer
was performed using Trans-Blot SD Semi-Dry Transfer Cell (Biorad) at 18 V for
60 min using PVDF membranes and transfer buffer (25 mM Tris, 192 mM glycine,
10% ethanol). The membrane was blocked in blocking buffer [PBS-T (Phosphate
buffered Saline tween-20; 3.2 mM Na2HPO4, 0.5 mM KH2PO4, 1.3 mM KCl,
135 mM NaCl, 0.05% Tween-20, pH 7.4.) with 5% skinny fat milk] for 60 min and
shaking at room temperature. Oct4, Oct6, and Actin antibodies were used at a
concentration of 0.4 µg per mL in PBS-T with 5% BSA and the membrane was
incubated overnight with rocking at 4 °C. On the next day, the membrane was
washed three times for 10 min in 1× PBS-T. Multiplexed IRDye secondary anti-
bodies (LI-COR) were used at a dilution 1:10,000 in 10 mL PBS-T with 5% BSA
and the membrane was incubated for 60 min at room temperature. After washing
with 1× PBST, the signals were detected using the 700 nm and 800 nm channels of
the Odyssey CLx imaging system (LI-COR). List of antibodies used in this study are
in Supplementary Table 11.
Electrophoretic mobility shift assays (EMSAs). EMSAs were performed using 5’
Cy5-labeled-dsDNA (Supplementary Table 5) as described previously26. Compli-
mentary strands of DNA probes were annealed in equimolar concentration using
1× annealing buffer (20 mM Tris–HCl, pH 8.0; 50 mM MgCl2; 50 mM KCl) by
heating to 95 °C for 5 min followed by decreasing to 4 °C with a ramp-rate of 1 °C
per min. Protein-DNA binding reactions were performed for 1 h in the dark at 4 °C
in 1× EMSA buffer (20 mM Tris-HCl pH 8.0, 0.1 mg per mL bovine serum
albumin, 50 mM ZnCl2, 100 mM KCl, 10% (volume by volume) glycerol, 0.1%
(volume by volume) igepal CA630 and 2 mM β-mercaptoethanol). A 12% native 1×
Tris-glycine (25 mM Tris pH 8.3; 192 mM glycine) polyacrylamide gel was pre-run
at 100 V for 30 min at 4 °C. The protein-DNA complexes were separated at 4 °C for
30 min at 200 V. Cy5-labeled DNA bands were imaged using a Typhoon FLA7000
laser scanner.
STARR reporter and STARR-seq assay. Cloning: Reporter plasmids were gen-
erated by cloning either gBlocks (IDT) or fragments obtained by nested PCR from
genomic ESC DNA into the STARR-seq screening vector (Addgene #7150938)
using In-Fusion® HD Cloning Kit (Takara, Clontech). The DNA fragments used in
reporter assays are listed in Supplementary Table 8. DNA fragments with described
enhancer function in response to activation by the Glucocorticoid receptor, which
is not expressed in stem cells, served as negative controls (nc1–3) for reporter
activation and to assess basal promoter activity. The STARR-seq library containing
DNA fragments isolated by formaldehyde assisted isolation of regulatory elements
(FAIRE)45 from E14 mouse ESC was obtained following the protocol described in
ref. 38. Reporter assays: To analyze individual reporter constructs, E14 mouse ESCs
were cultured on gelatin-coated plates at a density of 2.5 × 104 cells per well of a 24
well plate with ESC medium supplemented with 20% FBS and LIF (prepared in-
house). The next day, cells were washed with 1 mL PBS and fresh 400 μL ESC
medium was added. In addition, 100 μL transfection media containing 1 μg STARR
(self-transcribing active regulatory region) plasmid constructs38, 0.8 μL lipofecta-
mine 2000 (Invitrogen) in opti-MEM medium was added to each well. Cells were
collected after 24 h of transfection for FACS and qPCR analysis. For qPCR, RNA
was isolated using the Qiagen RNeasy minikit. For cDNA synthesis, 500 ng RNA
was used with gene-speciﬁc primers (GFP and Rpl19; Supplementary Table 6)
using Takara PrimeScript RT reagent kit with following cycle conditions, 42 °C for
30 min, 85 °C for 5 s, 4 °C for storing. Reporter expression was quantiﬁed by qPCR
speciﬁc for GFP and normalized to housekeeping gene (Rpl19) expression (primers
in Supplementary Table 7). To test the DNA fragments obtained by FAIRE for
their enhancer activity, 5 × 106 E14 ES cells were transfected with 5 μg of the
plasmid library using a NucleofectorTM 2b device (Lonza) with the Mouse ES Cell
Nucleofector Kit (VAPH-1001, Lonza). For each biological replicate, 4 individual
transfections were performed and subsequently combined for RNA isolation using
the RNeasy Midi kit (Qiagen) 16 h after transfection. The polyA RNA fraction was
enriched using Dynabeads Oligo(dT)25 (Invitrogen), residual DNA was digested
using Turbo DNase (Invitrogen) and ﬁnally RNA as cleaned-up with Agencourt
RNAClean XP beads (Beckman Coulter).
Real-time quantitative reverse transcription PCR. MEF cells and reprogram-
ming cells were washed once with PBS and lysed by the addition of TRIzol reagent
with incubation of 5 min at room temperature. Chloroform (0.2 mL per 1 mL
TRIzol) was added to samples and shaken vigorously for 15 s and incubated for
2–3 min at room temperature. The mixtures were centrifuged at 12,000×g for 15
min at 4 °C to separate them into three different phases. The upper aqueous phase
was transferred into a new micro-centrifuge tube. An equal volume of 70% ethanol
was added and vortexed. The samples were cleaned and eluted using PureLink
RNA Mini Kit (Ambion) according to the manufacturer’s instructions. cDNA
synthesis was done using the ReverTra Ace qPCR RT Master Mix (Toyobo). qPCR
reactions were conducted using the CFX96 system (Bio-Rad) and iTaq™ Universal
SYBR Green Supermix (BioRad, #172–5121) in biological triplicates, each per-
formed in technical triplicates, with a template amount of 100–150 ng cDNA for
each reaction. The ΔΔCT method52 was used to analyze the cycle threshold (CT)
values. We used Actin (Supplementary Fig. 4A) or Rpl37a (Fig. 5g) as reference
genes and, respectively, MEFs (passage 1) or ZHBTc4-ESCs cultured with Dox for
7 days as calibrator samples.
ChIP-sequencing. Reprogramming cells (7.5–10 × 106 per sample) were collected
by trypsinisation at 1, 5, and 7 dpt and washed twice with PBS (Thermo Fischer
Scientiﬁc, #14200–075). Cells were resuspended in PBS at a density of 5 × 105 per
mL and then chemically crosslinked by the addition of 1% formaldehyde (Thermo
Fischer Scientiﬁc, #28908) for 10 min at room temperature with gentle rotation.
Crosslinking was stopped by the addition of glycine (Sigma, #G8790) to a ﬁnal
concentration of 125 mM for 5 min at room temperature. Cells were washed twice
with 10 mL cold PBS and lysed in 10 mL Lysis Buffer 1 (150 mM NaCl, 0.5% NP40;
1 mM EDTA, 10% glycerol, 0.25% triton-X100, freshly added complete proteinase
inhibitor cocktail) in 15 mL tubes at 4 °C for 10 min with gentle rocking. The lysate
was centrifuged for 10 min at 1350 × g at 4 °C. The supernatant was discarded and
the pellet was resuspended in 10 mL lysis buffer 2 (10 mM Tris-HCl, pH 8.0, 200
mM NaCl, 1 mM EDTA, 0.5 mM EGTA, protease inhibitor) and incubated at 4 °C
for 10 min. The procedure was repeated using 10 mL lysis buffer 3 (1% SDS,
10 mM EDTA, 50 mM Tris-HCl, pH 8.0, protease inhibitor) and 10 min rocking
at RT. Nuclei were collected by centrifugation and washed twice with sonication
buffer (10 mM Tris-HCl, pH 8.0, 0.5 mM EDTA, protease inhibitor) and ﬁnally
resuspended in sonication buffer. Samples were sonicated using a Covaris S220
device with default settings to obtain DNA fragments with a length from 150 to
500 bp using 130 μL microTUBEs (Covaris, #520045) for 5–8 cycles with 30 s ON
and 60 s OFF. 10% Triton-X 100 (Sigma, #T8787) was added and the lysate
was centrifuged at high speed (20,000 × g for 10 min at 4 °C). 1 by 10th of the
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11054-7
12 NATURE COMMUNICATIONS |         (2019) 10:3477 | https://doi.org/10.1038/s41467-019-11054-7 | www.nature.com/naturecommunications
supernatant was stored as input control. ChIP was performed in an automated
fashion using the IP-Star compacted automated system (Diagenode) using 10 μg
ChIP-grade antibodies (Supplementary Table 11) for Oct4 (Santa Cruz Bio-
technology, # Sc-8628X), Oct6 (Santa Cruz Biotechnology, # Sc-11661X) or 10 μg
Sox2 (Santa Cruz Biotechnology, # sc-17320 X or Cell Signaling Technology,
#2748 s) and 50–100 μL protein G Dynabeads (Thermo Fischer Scientiﬁc,
#10004D). The coupling time for beads and antibody was 5 h followed by incu-
bation with lysate for 15 h at 4 °C. Automated wash steps of 10 min at 4 °C were
performed in the following order: low salt buffer (20 mM Tris-HCl pH 8.0, 0.1%
SDS 1% TritonX-100, 2 mM EDTA, 150 mM NaCl), high salt buffer (20 mM Tris-
HCl pH 8.0, 0.1% SDS 1% TritonX-100, 2 mM EDTA, 500 mM NaCl), LiCl buffer
(500 mM LiCl, 50 mM Tris-HCl pH 8.0, 2 mM EDTA, 1% NP-40, 0.5% Na-
deoxycholate), TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA) with ﬁnal elution
in 10 mM Tris-HCl pH 8.0, 1 mM EDTA, 1% SDS buffer. The eluted chromatin
and input samples were reverse‐crosslinked by overnight incubation at 65 °C.
Samples were treated with RNaseA (0.2 mg per mL ﬁnal concentration, Sigma,
#R6513) at 37 °C for 2 h followed by proteinase K (0.2 μg per mL ﬁnal conc.,
Thermo Fischer Scientiﬁc, #25530–049) at 55 °C for 3 h. DNA was extracted by
phenol:chloroform:isoamyl alcohol (25:24:1, (Fluka, #77617) and phase separated
using heavy phase-lock tubes (TianGen, #WM5–2302831) by centrifugation at
10,000 rpm for 10 min at RT and precipitated with 100% ethanol and 20 μg per μL
glycogen (Roche, #901393) as co-precipitant. The precipitate was washed with 80%
ethanol and ﬁnally eluted in 20 μL water. DNA concentration was determined
using Qubit dsDNA HS assay kit (Thermo Fischer Scientiﬁc, # Q32856).
RNA-sequencing. Reprogramming cells with cocktails containing SK along with
either of the following factors Oct4, Oct6, Oct4defSox2, and GFP were washed twice
with 1× PBS and collected by adding 250 μL TRIzol (Thermo Fisher Scientiﬁc,
#12183555) per well of a 12 well plate at days 0, 1, 3, 5, 8 in replicates. In addition,
MEF cells were also collected. Total RNA was isolated and used for library con-
structions with TruSeq Nano RNA sample prep kit (Illumina). Sequencing was
carried out on the Illumina HiSeq 2500 (Illumina). Each library was paired-end
with a 150 bp read length. Both RNA and ChIP sequencing were carried out at
Wuxi Next Code (https://www.wuxinextcode.cn/) and reads were provided in fastq
format for data analysis.
Assay for transposase-accessible chromatin using sequencing. ATAC-seq was
performed in replicate following this protocol40,53. Brieﬂy, 50,000 cells (repro-
grammed with Oct4-SK, Oct6-SK and Oct4defS2-SK retroviruses) were collected at
days 1 and 5 of reprogramming and processed by Annoroad Gene Technology
(http://en.annoroad.com/). Brieﬂy, cells were washed once with 50 μL of cold PBS;
centrifuged at 500 × g for 5 min at 4 °C and cell pellets were resuspended in 50 μL
cold ATAC lysis buffer (10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1%
IGEPAL CA-630) by slowly pipetting up and down and immediately spun down at
500×g for 10 min at 4 °C to collect nuclei. Nuclei were washed in 1× PBS and
subsequently re-suspended in 50 μL transposition reaction mix (25 μL 2× TD
reaction buffer, 22.5 μL nuclease-free water, 2.5 μL Tn5 transposase) of Nextera
DNA library preparation kit (Illumina, FC-121–1030). Samples were incubated at
37 °C for 30 min and DNA was isolated using minElute Kit (Qiagen). The trans-
posed DNA was then ampliﬁed with custom primers as described for 1 cycle of
72 °C for 5 min, 98 °C for 30 s followed by 5 cycles of 98 °C for 10 s, 63 °C for 30 s,
72 °C for 1 min. To determine the suitable number of cycles required for the next
round of PCR, the library was assessed by quantitative PCR as described in ref. 53.
Libraries were analyzed using the Bioanalyser high sensitivity DNA analysis kit
(Agilent) followed by paired-end sequencing with the length of 150 nucleotides.
Pluripotency maintenance assay. ZHBTc4 ESCs are engineered tet-off cells with
conditional repression of Oct4 in the presence of doxycycline (Dox), allowing to
test the Oct4-knockout rescuing ability by exogenously provided factors43. The
addition of Dox leads to the removal of the Oct4 protein after 24 h and tro-
phectodermal differentiation. The introduction of exogenous wild-type Oct4 with a
constitutive EF1α promoter rescues pluripotency in the presence of Dox. ZHBTc4
ESCs were cultured in the absence of Dox in ESC medium (high-glucose DMEM
medium (Life Technologies) supplemented with 15% KSR, 2% FCS, 1% Glutamax,
1% NEAA, 1% penicillin-streptomycin, 1% β-mercaptoethanol, and 20 ng per mL
human recombinant LIF (puriﬁed in-house at the Max Planck Institute for
Molecular Biomedicine) were split on gelatin-coated dish and simultaneously
infected with non-concentrated lentiviral pLVTHM-Oct4 or pLVTHM-Oct4defSox2
under constitutive EF1α promoter. After 48 h of infection, the cells were washed
with PBS and split on C3H mitotically inactivated feeder cells in ESC medium in
the presence of 2 μg per mL Dox (Sigma, #D9891). The cells were imaged after
6 days of culture (passage 1), and consequently passaged every 3–4 days in the
presence of feeders, in 1 to 50 or 1 to 10 density for wild-type Oct4 or Oct4defSox2,
respectively. For RNA preparation for the qPCR experiment, the cells were pas-
saged on gelatin-coated plates with no feeders in the presence in 2i medium [3 µM
CHIR99021 (Selleck; #S2924), 1 µM PD0325901 (Selleck; #S1036)54]. For immu-
nostaining, 1.6 × 104 cells per well were passaged in a 24 well plate with C3H
feeders, cultured in ESC medium supplemented with 2 μg per mL Dox for 3 days.
Brieﬂy, cells were ﬁxed with PFA, permeabilised with 0.1% TritonX100, blocked
with 5% BSA, incubated with primary antibodies overnight, washed with PBST,
and incubated with donkey anti-mouse, anti-rat, and anti-goat Alexa-ﬂuorophore-
conjugated secondary antibodies for 1 h (Supplementary Table 11).
For alkaline phosphatase (AP) staining, the passage 1 rescued cells (after 6 days
of Dox treatment), were ﬁxed with paraformaldehyde (PFA) and stained with fast
red pre-mixed with naphtol (Sigma; 855–20 mL).
Flow cytometry. MEFs and reprogramming intermediates at days 3, 5, and 8 were
dissociated with trypsin. Cells were collected by centrifugation at 300 × g for 5 min
and kept on ice hereafter in polystyrene test tubes (12 × 75 mm, non-sterile). Cells
were washed twice with 1 mL FACS buffer (1× PBS, 5% fetal bovine serum, 20 mM
HEPES pH 7.2–7.5). Cells were resuspended and blocked in blocking buffer (FACS
buffer containing 5% normal mouse serum (Gemini bio-products, #100–113)) at a
density of 1 × 106 cells per 100 µL and pre-incubated on ice for at least 10 min.
Cdh1 antibody (Thermo Fisher Scientiﬁc, #50−3249−82; 0.5 μg per sample,
Supplementary Table 11) or Mouse IgG1, κ Isotype Control (BD biosciences,
#555746; 5 μg per sample) was added directly to cells in blocking buffer and
incubated for 20–25 min in dark on ice. The unbound antibodies were washed
twice with 1 mL of cold FACS buffer. DAPI (BD biosciences, #564907) was used to
exclude dead cells. Cells were passed through a 40 μm cell strainer (Corning, #
CLS431750–50EA) before analysis on LSRFortessa machine (BD biosciences). The
gating strategy is shown in Supplementary Fig. 2B. Analysis was done with the
FlowJo V10 software.
Immunocytochemistry. Cells reprogrammed with Oct4-SK were washed three
times with PBS (1×) and ﬁxed with 4% paraformaldehyde for 15 min at room
temperature. Cells were permeabilised by incubation with 0.2% Triton X-100 for
15 min in 1× PBS at room temperature. The permeabilised cells were washed twice
with 1× PBS and blocked with 5% BSA in 1× PBS for 1 h. Cells were incubated with
primary Nanog antibody (Novus; #NB100–58842, 1:500, Supplementary Table 11)
at 4 °C overnight. Cells were washed three times with 1× PBS and incubated with
Alexa Fluor 594 Donkey anti-Rabbit IgG (H+ L) secondary antibody (Invitrogen;
#A21207, 1:1000) in the dark at room temperature for 1 h. Cells were washed three
times with 1× PBS and further stained with 1× DAPI (Thermo Fisher Scientiﬁc;
#R37606) and imaged with an Olympus CKX53 inverted ﬂuorescence microscope.
Whole-well scans were obtained by an ImageXpress Micro Confocal High-Content
Imaging System (Molecular Devices).
RNA-seq data processing. The mouse transcriptome index was generated with
RSEM55 using the reference genome mm10 (ensemble gene annotation track v74).
150 bp paired-end raw reads were aligned to the mm10 transcriptome using RSEM
and bowtie 2.0 (with options “rsem-calculate-expression -p 12–bowtie2–no-bam-
out–paired-end”)56. Per-gene read counts were calculated using RSEM and were
GC normalized using EDAseq57. A threshold of GC-normalized read count of 20 in
any two samples was applied to keep a gene, leading to a ﬁnal set of 15,026 genes.
This read count was used for differential gene expression analysis using DESeq258,
to inspect the expression of individual genes and to perform global clustering with
correlation heatmaps and principle component analysis in glbase59. PCA was
generated using the get_pca function and correlation heatmaps were generated
using correlation_heatmap function with option mode= r2 in glbase. The R
packages data.table and ggplot2 were used for data analysis and visualization.
STARR-seq data processing. Sequencing libraries were generated using the
Illumina Truseq dual index system with unique molecular identiﬁer (UMI) con-
taining primers for cDNA generation and barcoded PCR ampliﬁcation. Libraries
were sequenced with HiSeq 2500 (Illumina) to generate 50 bp paired-end reads.
Sequencing reads were aligned to the mouse genome (mm10) using Bowtie256
(-X 800 –fr–very-sensitive). UMI-tools60 was used for UMI-aware removal of PCR
duplicates. Samtools61 was used to ﬁlter reads for proper pairs, alignment and
quality scores (-h -b -f 3 -F 780 -q 5), to select reads mapping only to regular
chromosomes (chr1–19, chrX and chrY), and to remove reads mapping to
blacklisted regions (ENCODE accession ENCFF547MET). Accessible regions
covered by the input library were identiﬁed using MACS262 (-q 0.05–keep-dup
all–call-summits–bw 200). Signiﬁcantly active enhancers were called using MACS2
with the same settings but using the input library as control. The analysis was
performed for each biological STARR-seq replicate individually, as well as for the
merged reads from three replicates. Finally, peaks were only counted as true
STARR-seq enhancers when they were called for the merged reads and also called
for at least two of three replicates. Normalized STARR-seq signal for data visua-
lization was generated using bamCompare of the deepTools package63 (-of
bigwig–operation subtract -bs 10 -e–normalizeUsing RPKM–effectiveGenomeSize
2652783500) and replicate-merged STARR-seq reads were normalized to Input
library reads, as well as to sequencing depth.
Heatmaps which show STARR-seq signal distribution at selected regions were
generated using computeMatrix (reference-point mode) and plotHeatmap tools of
the deepTools package63.
To assess Oct4 or Oct6 bound regions for their STARR-seq activity, at day1 and
day 5 of reprogramming, ChIP-seq peaks were ﬁltered for sites, which are
represented in the STARR-seq library using bedtools intersect (Supplementary
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Fig. 9G). Next, these overlapping regions were grouped by enriched sequence
motifs (described in the motif analysis section) and for each group the input-
normalized STARR-seq signal was plotted (Supplementary Fig. 9H).
To show STARR-seq enhancer activity distribution at Oct4 bound regions in
mESCs, STARR-seq signal (not input normalized) was plotted at Oct4 bound sites
(GSE908955). Oct4 sites were ranked for mean STARR-seq signal and subsequently
STARR-seq input signal was plotted for these ranked Oct4 sites (Supplementary
Fig. 9F).
For the genome wide correlation analysis of read coverages, comparing FAIRE-
STARR-seq with DNase-seq (GSM101415446) coverage (Supplementary Fig. 9D),
multiBamSummary of the deepTools package was used. To this end the genome
was binned into 100 bp bins and reads mapping to each bin per sample were
counted while reads mapping to the blacklisted regions were excluded (-bs 100 -e
-bl ENCFF547MET). The resulting table was analyzed with R, the values (reads per
bin) log10 transformed, a Pearson correlation coefﬁcient was calculated and a
correlation plot was printed with the smoothScatter function.
Intersection analyses were performed using bedtools64 intersect (-wa -u);
STARR-seq input library peaks were intersected with DNase-seq peaks
(GSM101415446) (Supplementary Fig. 9E), Oct4 bound sites (GSE908955) with
STARR-seq input peaks (Supplementary Fig. 9F top Venn diagram) and the
resulting STARR-seq input covered Oct4 regions with active STARR-seq enhancers
(Supplementary Fig. 9F bottom Venn diagram).
ATAC-seq data processing. ATAC sequencing data were mapped to mouse
genome assembly (mm10) using bowtie2 (–very-sensitive–end-to-end–no-
unal–no-mixed -X 2000). Low quality mapped reads were removed using samtools
(view –q 30). PCR duplicates were removed using samtools (rmdup) to only keep
uniquely mapped reads. The BAM ﬁles of time point replicates of each sample were
merged with samtools (merge) prior to peak calling with MACS2 (-g mm -f
BAMPE). BigWig ﬁles were generated using genomeCoverageBed from bedtools64
and then bedGraphToBigWig. Library statistics are reported in (Supplementary
Table 2).
ChIP-seq data processing. Sequencing was performed by Wuxi AppTec
(Shanghai) Co., Ltd. The libraries were generated using the Truseq Nano DNA kit
(Illumina) and sequenced with a Hi-seq 2500 or Hi-seq X (Illumina) with paired-
end reads of 125 bp (day 7 Oct4-ChIP) or 150 bp for other samples. Library sta-
tistics are reported in (Supplementary Table 2). ChIP-seq reads were aligned to the
mouse genome (mm10) using Bowtie256 with settings end-to-end and very-
sensitive. Samtools61 was used to discard reads with mapping quality < 10 (sam-
tools view q= 30) and only unique reads were kept (samtools rmdup) to account
for PCR bias. Output BAM ﬁles were sorted using BEDTools64 sort function and
converted into BigWig track ﬁles65 using genomeCoverageBed followed by UCSC
utility bedgraphToBigWig. Peaks were called using MACS2 with options–call-
summits–to-large -p 0.0001 options62.
ChIP-seq correlation analysis. For corrplot in Fig. 3a, the peak ﬁles were
downloaded from the publically available GEO database [https://www.ncbi.nlm.
nih.gov/geo/]. All the peaks were converted to mm10 using UCSC’s LiftOver tool
[http://genome.ucsc.edu/]. Hierarchical clustering of the pairwise (R2) correlation
was performed using the glbase module compare with the options delta= 100,
method= “collide”, bracket= (0, 1), distance= “euclidean”)59.
ChIP-seq binary group analysis. We deﬁned the binary groups for sites bound by
Oct4 (Fig. 2a) or Oct4-and-Oct6 (Fig. 6a) at different stages of reprogramming
based on binary division in glbase59. ChIP-seq reads ﬁles in bed format were
subjected to glbase function “seqToTrk” with option format= format.bed to get trk
ﬁles. These generated trk ﬁles and ChIP-seq peak summits were used for binary
group deﬁnitions. The summits of the peaks from all time points (in Oct4 case,
days 1, 5, and 7) or summits of peaks from both TFs (Oct4 and Oct6) from days 1
and 5 were merged if they were within 100 bp and a binary deﬁnition (1= bound,
0= not bound) for each locus was deﬁned thus resulting in 7 (for Oct4 day 1, 5,
and 7 ChIPseq) and 15 (for Oct4 and Oct6 ChIPs at days 1 and 5) groups,
respectively.
Motif analysis. The ﬁndMotifsGenome.pl function of HOMER was used for de
novo motif discovery in 200 bp regions (-size −100,100) of ChIP-seq summits with
motif lengths set to 12, 14, and 16 bp (-len 12,14,16) with additional options
-mm10 -p866. For calculating motif fractions, motif scanning was performed using
the annotatePeaks.pl function (mm10, -size −100,100 -mbed) with PWMs for
SoxOct, MORE, MORE+1 and Octamer motifs. For palindromic motifs –norevopp
option was used to avoid double counts.
chromVAR analysis. For ATAC-seq data, chromVAR41 was used to compare the
chromatin accessibility variation for peaks marked by different TF motifs. Peaks in
narrow peak format called with macs2 from Oct4, Oct6, Oct4defSox2 samples at
days 1 and 5 (this study), as well as previously published MEFs and ESCs samples42
were combined and resized to 500 bp yielding a count matrix where rows are peaks,
columns ATAC-seq conditions and ﬁelds read counts. For overlapping peaks, the
peaks with higher peak scores or overall higher read counts were kept. Motif
PWMs from the HOMER database were obtained with the chromVARmotif R
package. Motif matches in peak regions were assigned using the motifmatchr
package. GC bias corrected accessibility deviations were calculated based on
merged reads from ATAC-seq replicates. For better comprehension, the two motifs
from HOMER database are renamed as MORE (OCT:OCT(POU, Homeobox,
IR1)) and MORE+ 1 (OCT:OCT(POU, Homeobox)). Accessibility variability data
are presented as a heatmap using the pheatmap R package.
Gene ontology (GO). Differentially expressed gene lists were generated from
RNA-seq data from day 8 Oct4-SK and Oct6-SK conditions using GFP-SK as
reference. Genes were ﬁltered with log2 fold-change more than two as criteria and
enriched GO terms were determined with the Metascape67.
ChIP-seq and ATAC-seq read intensity analysis. EAseq v.1.0468 was used to
draw all the ChIP-seq and ATAC-seq read heat maps using EAseq normalization
(DNA fragments per kilobase pairs (kbp) per million (M) reads) for each peak ﬁle
from indicated libraries. For each location, the heatmap signal is displayed by
centering at the peak midpoints or on TF motifs. In order to sort the heatmaps by
ChIP or ATAC library signal, coverage from the corresponding library was cal-
culated using bedtools multicov. For ATAC-seq and Sox2 ChIP-seq the EAseq
normalized read intensities were used to plot boxplots. As the library size differ-
ences were bigger for POU ChIP-seq libraries quantile normalization was used for
boxplots. POU ChIP-seq coverage was calculated using bedtools multicov, a
pseudo-count of 1 was added to the raw coverage values and reads were subse-
quently quantile normalized using the normalize.quantiles.robust function in R
(preprocessCore package). For all the ChIP-seq and ATAC-seq signal boxplots in
paper, central rectangle represents the ﬁrst to third quartiles with median as central
line. The whiskers indicate 1.5 times interquartile range.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The datasets supporting the conclusions of this article are available in the Gene
Expression Omnibus (GEO), under accession number GSE103980. The authors declare
that the data supporting the ﬁndings of this study are available within the article and
its Supplementary Information ﬁles, or from the corresponding author upon reasonable
request. A Reporting Summary for this Article is available as a Supplementary
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Figs. 2B-C, 3B, 3H, 4A, and 4B are provided as a Source Data ﬁle.
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